| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.4M | — |
| R&D Expense | $5.9M | -7.9% |
| SG&A Expense | $59.5M | +5.0% |
| Operating Income | -$181.4M | -24.8% |
| Pre-tax Income | -$181.6M | +37.2% |
| Income Tax | $970K | +1327.8% |
| Net Income | -$182.6M | +36.9% |
| EPS (Basic) | -$1.08 | +38.3% |
| EPS (Diluted) | -$1.21 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $156.7M | +899.1% |
| Accounts Receivable | $2.0M | — |
| Inventory | $9.4M | +15.9% |
| Current Assets | $198.0M | +267.4% |
| Total Assets | $922.7M | +15.6% |
| Current Liabilities | $87.6M | -3.6% |
| Total Liabilities | $572.1M | -7.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$142.7M | +1.4% |
| Capital Expenditures | $40.8M | -26.5% |
| Investing Cash Flow | -$54.5M | -677.1% |
| Financing Cash Flow | $323.7M | +396.5% |
| Free Cash Flow | -$183.6M | +8.4% |
| +30.9% |
| Stockholders' Equity |
| $45.9M |
| -74.6% |